Stocks  /  NASDAQ  /  First Tracks Biotherapeutics Inc.

First Tracks Biotherapeutics Inc.

Industry:   Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol:   TRAX – NASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

First Tracks Biotherapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for drug testing.

“ANB033, a Novel CD122 Antagonist in Development for the Treatment of Inflammatory and Autoimmune Diseases, Inhibited IL-15 and IL-2 Signaling in CD8+ and CD4+ T Cells In Vitro and in a Murine Model of GvHD” Read the full document

Company Description

First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States. First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was founded in 2019 and is based in San Diego, California.

Company Website: https://www.firsttracksbio.com

Contact:  info@firsttracksbio.com
Scroll to Top